Navigation Links
AVANIR Pharmaceuticals To participate in two conferences in March
Date:3/1/2013

ALISO VIEJO, Calif., March 1, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the following conferences in March.

(Logo: http://photos.prnewswire.com/prnh/20130207/LA55901LOGO)

  • Cowen & Company 33rd Annual Healthcare Conference
    • Location: Boston Marriott Copley Place, Boston, MA
    • Presentation date: Tuesday March 5, 2013
    • Presentation time: 9:20 a.m. E.T.
  • 25th Annual ROTH Conference
    • Location: Ritz-Carlton, Laguna Niguel, CA
    • Presentation date: Wednesday March 20, 2013
    • Presentation time: 11:30 a.m. P.T.

A live webcast and 30-day archive of these presentations will be available at http://ir.avanir.com.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc. in the United States and other countries.

©2013
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference
2. Avanir Pharmaceuticals Reports Fiscal 2012 Third Quarter Financial And Business Results
3. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
4. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
5. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
6. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
7. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
8. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
9. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
10. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
11. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013 Oven Industries Inc. announces ... 5R6-900 temperature controller has many user-friendly benefits. Contained all ... the wall as a self-contained temperature control ... detail makes the device unique, as well as highly ... also be used universally, which allows the user to ...
(Date:5/17/2013)... is available in German . ... with the naked eye, you can see which branch a ... blur of branches through the telephoto lens for high-magnification images ... who are looking to study proteins, the active biomolecules of ... Institute for Molecular Systems Biology, and her colleagues have now ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 The new ... Photonics21 at the association’s recent annual meeting drew ... EC Vice-President Neelie Kroes, who called the action “a ... and a stimulant to European innovation.” , The Board ... of the new Photonics PPP at its 29 April ...
(Date:5/17/2013)... PHILADELPHIA , May 17, 2013 ... held by the most innovative thought leaders of ... Device & Manufacturing East conference and expo, from ...      (Photo: http://photos.prnewswire.com/prnh/20130517/613829 ) ... were designed to deliver industry professionals practical presentations ...
Breaking Biology Technology:New Temperature Control Products Announced by Oven Industries Inc. 2Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 3MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2
... LAIYANG, China, Sept. 2 /PRNewswire-Asia-FirstCall/ -- Jiangbo,Pharmaceuticals, Inc. (OTC ... with its principal operations in the People,s,Republic of China, ... will,present at the upcoming Rodman & Renshaw Annual Global ... New York Palace Hotel in New York City. , ...
... , , SOUTH SAN ... announced the first commercial sales of a new ... treatment of New York Heart Association Class III and IV ... same dose of Ventavis in half the volume, which is ...
... KALAMAZOO, Mich., Sept. 1 Stryker Corporation (NYSE: ... , Lonny J. Carpenter, currently Group President, ... President, Global Quality and Operations, reporting to Stephen P. MacMillan, ... Carpenter will be responsible for setting and executing company-wide quality, ...
Cached Biology Technology:Jiangbo Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference 2Jiangbo Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference 3Actelion Launches Increased Strength Formulation of Ventavis (Iloprost) for Pulmonary Arterial Hypertension in the United States 2Actelion Launches Increased Strength Formulation of Ventavis (Iloprost) for Pulmonary Arterial Hypertension in the United States 3Stryker Announces Organizational Changes 2
(Date:5/17/2013)... investigating the interaction of a group of proteins in ... have identified a new target that could increase cell ... University,s School of Biochemistry and published in the ... could eventually lead to new therapies for stroke and ... work by the team which identified a protein, known ...
(Date:5/17/2013)... A new Dartmouth College study finds human-caused climate ... of tropical lizards, contradicting a host of recent ... rapidly warming planet. , The findings, which appear ... offer new hope for survival of a creature ... Most predictions that tropical cold-blooded animals, especially forest ...
(Date:5/16/2013)... Bethesda, MD (May 17, 2013) Illustrating a ... the American Gastroenterological Association (AGA) Research Foundation ... Future Student Research Fellowship Award recipients. Supported by ... Kidney Diseases (NIDDK), this new award helps underrepresented ... digestive disease and nutrition research. , "By establishing ...
Breaking Biology News(10 mins):SUMO wrestling cells reveal new protective mechanism target for stroke 2Climate change may have little impact on tropical lizards 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2
... undergoing a unique and innovative surgery at Michigan State University, ... his time working out on an underwater treadmill, traversing obstacle ... yellow Labrador retriever, was the first dog in the Midwest ... for a new, cementless elbow prosthesis last April. The procedure, ...
... in the root of a tropical grass whose oils ... These bacteria seem to promote the production of essential ... the oil, giving it different flavours and properties: termicidal, ... the tropical Vetiver grass through interdisciplinary research, the microbiologists ...
... of all food allergies are not food allergies at ... allergologists from Wrzburg University, concluded in a study with ... Deutsches rzteblatt International (Dtsch Arztebl Int 2008; ... allergy testing, food allergy was only confirmed in 214 ...
Cached Biology News:Innovative surgery by MSU veterinarian provides new lease on life to dogs 2Bacteria manage perfume oil production from grass 2
Mouse monoclonal antibody raised against a partial recombinant ZNF167. NCBI Entrez Gene ID = ZNF167...
... Proteins ,Contains sufficient components to prepare ... gel analysis , ,Includes:, , Mem-PER ... , (contains sufficient reagents for extracting 25 ... of 10 mg each) Kit , ...
Mouse monoclonal antibody raised against a partial recombinant PUM2. NCBI Entrez Gene ID = PUM2...
... high speed homogeneous assay for the detection ... screening of inhibitors in a high-throughput screening ... a fluorescence superquenching technology that does not ... platform provides flexibility for assaying any kinase ...
Biology Products: